Merck and ISB Collaborate to Understand and Treat SARS-CoV-2 Infection
heath.isbscience.org/2020/04/27/merck-isb-covid/
heath.isbscience.org/2020/04/27/merck-isb-covid/Recent Articles
Metabolic Changes in Plasma and Immune Cells Associated with COVID-19 Severity, May Predict Patient Survival
Researchers from Institute for Systems Biology (ISB), Fred Hutchinson Cancer Research Center and other organizations have uncovered underlying metabolic changes that regulate how immune cells react to COVID-19. These findings are associated with COVID-19 severity and may predict patient survival. The work was published in the journal Nature Biotechnology.
Looking at Tumors Through a New Lens
To improve the efficacy of neoadjuvant immune checkpoint blockade against glioblastoma, researchers are looking for vulnerabilities in surgically removed tissues – a difficulty due to the vast differences within the tumor and between patients. To address this, ISB researchers and their collaborators developed a new way to study tumors.
Dr. Temple Grandin and the Importance of Getting Kids Outside
Dr. Temple Grandin was the featured guest of the latest ISB-Town Hall Seattle Science Series. Grandin discussed her new book – “The Outdoor Scientist: The Wonder of Observing the Natural World” – and a variety of other topics. Following her talk, she joined ISB President Dr. Jim Heath for a wide ranging Q&A discussion.